Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22,222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study.
Fan R, Huang X, Nian X, Ou Z, Zhou J, Zhang J, Zeng P, Zhao W, Deng J, Chen W, Chen S, Duan K, Chen Y, Li X, Zhang J, Yang X. Fan R, et al. Among authors: zhao w. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-9. doi: 10.1080/21645515.2021.1967041. Epub 2021 Sep 2. Hum Vaccin Immunother. 2022. PMID: 34473607 Free PMC article. Clinical Trial.
Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial.
Huang X, Fan T, Li L, Nian X, Zhang J, Gao X, Zhao W, Chen W, Zhang Z, Yao Z, Han X, Shi J, Wang Y, Bian H, Shi N, Li X, Duan K, Li G, Yang X. Huang X, et al. Among authors: zhao w. Hum Vaccin Immunother. 2022 Nov 30;18(5):2079924. doi: 10.1080/21645515.2022.2079924. Epub 2022 Jun 17. Hum Vaccin Immunother. 2022. PMID: 35714276 Free PMC article. Clinical Trial.
Identifying Potential Candidate Hub Genes and Functionally Enriched Pathways in the Immune Responses to Quadrivalent Inactivated Influenza Vaccines in the Elderly Through Co-Expression Network Analysis.
Yang J, Zhang J, Fan R, Zhao W, Han T, Duan K, Li X, Zeng P, Deng J, Zhang J, Yang X. Yang J, et al. Among authors: zhao w. Front Immunol. 2020 Dec 4;11:603337. doi: 10.3389/fimmu.2020.603337. eCollection 2020. Front Immunol. 2020. PMID: 33343577 Free PMC article. Clinical Trial.
Rabies Virus Neutralizing Activity, Safety, and Immunogenicity of Recombinant Human Rabies Antibody Compared with Human Rabies Immunoglobulin in Healthy Adults.
Zhang JN, Meng YJ, Bai YH, Li YF, Yang LQ, Shi NM, Han HX, Gao J, Zhu LJ, Li SP, Zhang J, Zhao QH, Wang XQ, Wei JS, Ren LM, Cao CH, Chen C, Zhao W, Li L. Zhang JN, et al. Among authors: zhao qh, zhao w. Biomed Environ Sci. 2022 Sep 20;35(9):782-791. doi: 10.3967/bes2022.103. Biomed Environ Sci. 2022. PMID: 36189993 Free article. Clinical Trial.
Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study.
Li L, Li Y, Bai Y, Li G, Zhang J, Yang L, Zhao W, Zhao W, Luo F, Zhao Q, Zhang Z, Liu Y, Li S, Lu Q, Wang H, Zhang J, Zhang Y, Gao J, Shi N. Li L, et al. Among authors: zhao w, zhao q. Vaccine. 2022 Oct 6;40(42):6153-6162. doi: 10.1016/j.vaccine.2022.09.022. Epub 2022 Sep 16. Vaccine. 2022. PMID: 36123259 Free article. Clinical Trial.
22,222 results
You have reached the last available page of results. Please see the User Guide for more information.